Work

c15-160: Enzalutamide (ENZA) plus CC-115 in men with metastatic castration-resistant prostate cancer (mCRPC): A phase 1b Prostate Cancer Clinical Trials Consortium study.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.5045

Authors: Dana E. Rathkopf, Karen A. Autio, Emmanuel S. Antonarakis, Heather H. Cheng, Gabrielle Arauz, Annelise Slack, Melanie Hullings, Howard I. Scher, Felix Y Feng, Karen E. Knudsen

Institutions: Memorial Sloan Kettering Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, University of Washington, University of California, San Francisco, Thomas Jefferson University, Sidney Kimmel Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890270516

Cites:

Cited by: 4

Related to: 10